Publication
Navigating the IPO
Taking your company public is an important milestone, and whilst the landscape for IPOs is complex and dynamic, choosing the right path is essential.
Mitigating tariff risks for healthcare in US and Canada
Law 360
The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.
On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]
Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."
Partner
Email
jeff.wurzburg@nortonrosefulbright.com
Recent publications
Publication
Popularity of deal insurance set to soar
Now in its third year, our Global M&A Trends and Risks report, published in partnership with Mergermarket, captures insights from senior dealmakers across the world on the key risks and opportunities shaping mergers and acquisitions (M&A) deal activity in 2025.
Subscribe and stay up to date with the latest legal news, information and events . . .